• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Azathioprine and 6-mercaptopurine have a role in the treatment of Crohn's disease.

作者信息

Lennard-Jones J E

出版信息

Dig Dis Sci. 1981 Apr;26(4):364-8. doi: 10.1007/BF01308381.

DOI:10.1007/BF01308381
PMID:7016483
Abstract
摘要

相似文献

1
Azathioprine and 6-mercaptopurine have a role in the treatment of Crohn's disease.硫唑嘌呤和6-巯基嘌呤在克罗恩病的治疗中发挥作用。
Dig Dis Sci. 1981 Apr;26(4):364-8. doi: 10.1007/BF01308381.
2
Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.硫唑嘌呤或6-巯基嘌呤用于诱导克罗恩病缓解。
Cochrane Database Syst Rev. 2009 Oct 7(4):CD000545. doi: 10.1002/14651858.CD000545.pub2.
3
Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease.硫唑嘌呤或6-巯基嘌呤用于维持克罗恩病的缓解状态。
Cochrane Database Syst Rev. 2009 Jan 21(1):CD000067. doi: 10.1002/14651858.CD000067.pub2.
4
Use of 6-mercaptopurine/azathioprine as the immunomodulator of choice for moderately active Crohn's disease: balance.
Inflamm Bowel Dis. 2005 Feb;11(2):203-5. doi: 10.1097/00054725-200502000-00016.
5
Use of 6-mercapturine/azathioprine as the immunomodulator of choice for moderately active Crohn's disease: con.
Inflamm Bowel Dis. 2005 Feb;11(2):200-2. doi: 10.1097/00054725-200502000-00015.
6
Use of 6-mercaptopurine/azathioprine as the immunomodulator of choice for moderately active Crohn's disease: pro.使用6-巯基嘌呤/硫唑嘌呤作为中度活动性克罗恩病的首选免疫调节剂：支持观点
Inflamm Bowel Dis. 2005 Feb;11(2):197-9. doi: 10.1097/00054725-200502000-00014.
7
Pharmacotherapy of inflammatory bowel disease. Part 3. 6-Mercaptopurine.炎症性肠病的药物治疗。第3部分。6-巯基嘌呤。
Postgrad Med. 1983 Dec;74(6):165-72. doi: 10.1080/00325481.1983.11698539.
8
Shortcomings of the National Crohn's Disease Study: the exclusion of azathioprine without adequate trial.
Gastroenterology. 1981 Jan;80(1):193-6.
9
Azathioprine and 6 Mercaptopurine in postoperative maintenance of Crohn's disease remission: is no evidence of effect an evidence of no effect?硫唑嘌呤和6-巯基嘌呤用于克罗恩病缓解期术后维持治疗：无效应证据是否即证明无效？
Gastroenterology. 2005 Jan;128(1):246-8; author reply 248-9. doi: 10.1053/j.gastro.2004.11.035.
10
Experts Opinion on the Practical Use of Azathioprine and 6-Mercaptopurine in Inflammatory Bowel Disease.硫唑嘌呤和6-巯基嘌呤在炎症性肠病中的实际应用专家意见
Inflamm Bowel Dis. 2016 Nov;22(11):2733-2747. doi: 10.1097/MIB.0000000000000923.

引用本文的文献

1
Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.硫唑嘌呤或6-巯基嘌呤用于诱导克罗恩病缓解
Cochrane Database Syst Rev. 2016 Oct 26;10(10):CD000545. doi: 10.1002/14651858.CD000545.pub5.
2
Exome sequencing and array-based comparative genomic hybridisation analysis of preferential 6-methylmercaptopurine producers.优先产生6-甲基巯基嘌呤者的外显子组测序及基于芯片的比较基因组杂交分析
Pharmacogenomics J. 2015 Oct;15(5):414-21. doi: 10.1038/tpj.2015.9. Epub 2015 Mar 10.
3
6-Mercaptopurine-related pancreatitis in 2 patients with inflammatory bowel disease.

本文引用的文献

1
Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study.用6-巯基嘌呤治疗克罗恩病。一项长期、随机、双盲研究。
N Engl J Med. 1980 May 1;302(18):981-7. doi: 10.1056/NEJM198005013021801.
2
Treatment of Crohn's disease with azathioprine: a controlled evaluation.
Gastroenterology. 1974 May;66(5):916-22.
3
Azathioprine in ulcerative colitis: final report on controlled therapeutic trial.硫唑嘌呤治疗溃疡性结肠炎：对照治疗试验的最终报告
Br Med J. 1974 Dec 14;4(5945):627-30. doi: 10.1136/bmj.4.5945.627.
2例炎症性肠病患者发生与6-巯基嘌呤相关的胰腺炎。
Dig Dis Sci. 1984 Apr;29(4):357-9. doi: 10.1007/BF01318523.
4
Toward optimal use of corticosteroids in ulcerative colitis and Crohn's disease.实现溃疡性结肠炎和克罗恩病中皮质类固醇的最佳使用。
Gut. 1983 Mar;24(3):177-81. doi: 10.1136/gut.24.3.177.
5
Immunopathology of ulcerative colitis and Crohn's disease, nonsurgical therapeutic considerations.溃疡性结肠炎和克罗恩病的免疫病理学，非手术治疗考量
Eur J Pediatr. 1982 Nov;139(3):162-4. doi: 10.1007/BF01377348.
6
Inflammatory bowel disease.炎症性肠病
CMAJ. 1989 Jul 15;141(2):113-23; discussion 123-4.
4
Azathioprine for Crohn's disease.硫唑嘌呤用于治疗克罗恩病。
Lancet. 1969 Sep 20;2(7621):612-4. doi: 10.1016/s0140-6736(69)90325-0.
5
Controlled trial of azathioprine in Crohn's disease.
Lancet. 1971 Dec 11;2(7737):1273-6. doi: 10.1016/s0140-6736(71)90598-8.
6
Controlled trial of azathioprine in Crohn's disease.
Lancet. 1971 Oct 30;2(7731):944-7. doi: 10.1016/s0140-6736(71)90268-6.
7
A controlled trial of azathioprine in Crohn's disease.硫唑嘌呤治疗克罗恩病的对照试验。
Am J Dig Dis. 1975 Aug;20(8):721-6. doi: 10.1007/BF01070829.
8
Immunosuppression in the treatment of inflammatory bowel disease. II. The effects of azathioprine on lymphoid cell populations in a double blind trial in ulcerative colitis.免疫抑制在炎症性肠病治疗中的应用。II. 硫唑嘌呤对溃疡性结肠炎双盲试验中淋巴细胞群体的影响。
Clin Exp Immunol. 1976 May;24(2):249-58.
9
Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs.英国和澳大利亚关于接受免疫抑制药物治疗患者癌症的联合研究。
Br Med J. 1979 Dec 8;2(6203):1461-6. doi: 10.1136/bmj.2.6203.1461.
10
Double-blind withdrawal trial of azathioprine as maintenance treatment for Crohn's disease.硫唑嘌呤作为克罗恩病维持治疗的双盲撤药试验。
Lancet. 1978 Nov 4;2(8097):955-7. doi: 10.1016/s0140-6736(78)92524-2.